Sex differences in cancer outcomes, including glioblastoma (GBM), are shaped by biological, hormonal, and immune factors, influencing disease progression, treatment responses, survival, and the tumor ...

Including Nobel laureates, climate researchers, and parents of kids saved by groundbreaking drugs.

The Trump administration is exploiting a loophole to keep a funding freeze in place, leaving researchers in limbo.

A small sampling of clinical advances, promising medical advances, and insights from the lab by NIH-supported scientists.

Abstract: Background: Venous thromboembolisms (VTEs) are the second leading cause of death in cancer patients. While previous analyses have demonstrated VTE rates are greater in GBM patients using sma...

Exploring how aging compromises antitumor immunity, the authors reveal an age-related impairment of cytotoxic CD8+ TRM cells in mouse tumor models and clinical samples. They implicate BFAR signaling a...